Our partners in Singapore & Cambodia
Our partners in India
We partner with leading clinics worldwide in our Randomized Controlled Trials (RCTs), contributing to critical data collection that is helping shape the future of IVF treatment.
We are currently recruiting clinics to the global RCT for ORA™, our non-invasive endometrial receptivity test. If you are interested in participating, fill out the form at the bottom of the page, or contact [email protected].
Inti Labs partners with advanced technologies that enhance our offerings and elevate patient care.
Embryo46 is the premiere PGT-A solution for clinicians and patients looking to gain higher resolution insights into the health of their embryos. In addition to standard PGT-A analysis, Embryo46 also tests for Uniparental Disomy (UPD) and ploidy status (PN Check).
Contact Us to learn more about Embryo46!
Whether you’re a distributor seeking to expand your portfolio, a clinic eager to join our RCT community, or a provider of a complementary technology, let’s Refine the Fertility Journey together.
Fill out the form or reach out to us at [email protected].
